You searched for "snoring"
Evidence-based hospital management of epistaxis
Epistaxis is the most common presentation to acute ENT services in the UK. However, there are currently no nationally accepted guidelines for its management. The British Rhinological Society, ENT UK and INTEGRATE (The National ENT Trainee Research Network) are working...
Tongue tie – just a snip?
This article regarding ankyloglossia raises an eyebrow; surely it’s just a snip isn’t it? Seemingly not. The authors describe two types of tongue tie – the first being posterior, with the frenulum being short and tight, the second being anterior,...
Surgical indications for infantile haemangiomas
Infantile haemangiomas are embryonal tumours and represent the most common tumour of infancy, with an estimated incidence 4-5%. There is well-described natural history, usually becoming apparent in the first few weeks of life and proliferating rapidly in the first few...
MedShr-ing is caring
MedShr is an international, award-winning medical education platform that has been created for healthcare professionals (HCPs) to discuss, learn, teach, and (to a lesser degree) network with one another. MedShr was founded in 2014 by Cardiologist Dr Asif Qasim and,...Congenital cytomegalovirus causing deafness in children: an update
Congenital CMV is the leading non-genetic cause of sensorineural hearing loss in children. Keith Trimble draws our attention to this and gives a comprehensive guide on diagnosis and treatment. Congenital cytomegalovirus (cCMV) infection is common, affecting 1% of all newborns,...The UK National Eye Health and Hearing Study
A pilot study is currently underway in preparation for a UK National Eye Health and Hearing Study (UKNEHS). This will help to ensure an up-to-date and comprehensive picture of sight and hearing loss among over 50s in the UK.
Immunosuppresants and ototoxicity
There is a wide range of immunosuppressant drugs ranging from calcineurin inhibitors (e.g. cyclosporine), anti-folic agents (e.g. methotrexate) to anti-TNF and monoclonal antibodies, many of which could be ototoxic. The authors performed a systematic review assessing ototoxicity secondary to immunosuppressant...
Person-centric practice within a hearing wellbeing programme
This Australian team describe their development process of a hearing wellbeing programme beginning in August 2020, with a wide variety of stakeholders being involved. Primarily, they report, they aimed to overcome the challenge of providing engaging social and emotional support...New technology from GN Hearing addresses the No.1 hearing aid challenge: hearing speech in noise
ReSound OMNIA, the latest innovation from GN Hearing, promises to set a new standard in hearing technology.
Thalidomide in HHT
An interesting paper from a specialist centre in the Netherlands regarding the use of thalidomide in HHT patients. The St Antonius hospital has 1238 patients with HHT and 1% of these use thalidomide. The aim was to assess the benefits,...
